Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
DOYLESTOWN, PENNSYLVANIA and HALIFAX, NOVA SCOTIA--(Marketwire - Feb. 23, 2011) - Immunotope Inc. and Immunovaccine Inc. (TSX VENTURE:IMV) announced today that the U.S. Patent and...
-
HALIFAX, NOVA SCOTIA--(Marketwire - Feb. 10, 2011) - Immunovaccine Inc. (TSX VENTURE:IMV), a clinical-stage vaccine development Company, is pleased to provide an update on corporate...
-
HALIFAX, NOVA SCOTIA--(Marketwire - Feb. 2, 2011) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV) announced today that it has issued 12,000 common...
-
HALIFAX, NOVA SCOTIA--(Marketwire - Jan. 5, 2011) - Immunovaccine Inc. (TSX VENTURE:IMV) announced today that Dr. Randal Chase, President and CEO, will present at Biotech Showcase on...
-
HALIFAX, NOVA SCOTIA--(Marketwire - Jan. 4, 2011) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV) announced today that it has issued 11,843 common shares of its...